View source for 18483651. Tricyclic Compounds and their Uses simplified abstract (Novartis AG)

=Tricyclic Compounds and their Uses=


==Organization Name==

[[:Category:Novartis AG|Novartis AG]]


[[Category:Novartis AG]]

==Inventor(s)==

[[:Category:Vincent Bordas of Village-Neuf (FR)|Vincent Bordas of Village-Neuf (FR)]][[Category:Vincent Bordas of Village-Neuf (FR)]]

[[:Category:Markus Furegati of Allschwil (CH)|Markus Furegati of Allschwil (CH)]][[Category:Markus Furegati of Allschwil (CH)]]

[[:Category:Jacques Hamon of Habsheim (FR)|Jacques Hamon of Habsheim (FR)]][[Category:Jacques Hamon of Habsheim (FR)]]

[[:Category:Jürgen Hans-Hermann Hinrichs of Schopfheim (DE)|Jürgen Hans-Hermann Hinrichs of Schopfheim (DE)]][[Category:Jürgen Hans-Hermann Hinrichs of Schopfheim (DE)]]

[[:Category:Ziyue Hong of Shanghai (CN)|Ziyue Hong of Shanghai (CN)]][[Category:Ziyue Hong of Shanghai (CN)]]

[[:Category:Fabio Lima of Saint Louis (FR)|Fabio Lima of Saint Louis (FR)]][[Category:Fabio Lima of Saint Louis (FR)]]

[[:Category:Fatma Limam of Strasbourg (FR)|Fatma Limam of Strasbourg (FR)]][[Category:Fatma Limam of Strasbourg (FR)]]

[[:Category:Henrik Moebitz of Arlesheim (CH)|Henrik Moebitz of Arlesheim (CH)]][[Category:Henrik Moebitz of Arlesheim (CH)]]

[[:Category:Sandro Nocito of Wölflinswil (CH)|Sandro Nocito of Wölflinswil (CH)]][[Category:Sandro Nocito of Wölflinswil (CH)]]

[[:Category:Niko Schmiedeberg of Riehen (CH)|Niko Schmiedeberg of Riehen (CH)]][[Category:Niko Schmiedeberg of Riehen (CH)]]

[[:Category:Joseph Schoepfer of Riehen (CH)|Joseph Schoepfer of Riehen (CH)]][[Category:Joseph Schoepfer of Riehen (CH)]]

[[:Category:Ross Sinclair Strang of Hagenthal le Bas (FR)|Ross Sinclair Strang of Hagenthal le Bas (FR)]][[Category:Ross Sinclair Strang of Hagenthal le Bas (FR)]]

[[:Category:Frédéric Zecri of Brookline MA (US)|Frédéric Zecri of Brookline MA (US)]][[Category:Frédéric Zecri of Brookline MA (US)]]

[[:Category:Huangchao Yu of Suzhou (CN)|Huangchao Yu of Suzhou (CN)]][[Category:Huangchao Yu of Suzhou (CN)]]

[[:Category:Yong Zhang of Suzhou (CN)|Yong Zhang of Suzhou (CN)]][[Category:Yong Zhang of Suzhou (CN)]]

[[:Category:Xinkan Yang of Suzhou (CN)|Xinkan Yang of Suzhou (CN)]][[Category:Xinkan Yang of Suzhou (CN)]]

[[:Category:Sisi Zhang of Suzhou (CN)|Sisi Zhang of Suzhou (CN)]][[Category:Sisi Zhang of Suzhou (CN)]]

[[:Category:Wei Li of Suzhou (CN)|Wei Li of Suzhou (CN)]][[Category:Wei Li of Suzhou (CN)]]

==Tricyclic Compounds and their Uses - A simplified explanation of the abstract==


This abstract first appeared for US patent application 18483651 titled 'Tricyclic Compounds and their Uses

The present invention provides a compound, or a pharmaceutically acceptable salt thereof, of formula (I).

**Key Features and Innovation:**
* The invention introduces a novel compound or salt with potential pharmaceutical applications.
* The formula (I) represents a unique chemical structure that may have therapeutic benefits.
* This innovation opens up possibilities for new drug development and treatment options.

**Potential Applications:**
The compound or salt could be explored for use in various medical treatments, such as in the pharmaceutical industry for developing new drugs.

**Problems Solved:**
This technology addresses the need for novel compounds or salts that could potentially lead to the development of effective pharmaceutical products.

**Benefits:**
* The invention may contribute to advancements in the field of medicine and drug discovery.
* It offers the potential for improved treatment options for various medical conditions.

**Commercial Applications:**
The compound or salt could have commercial applications in the pharmaceutical industry, leading to the development of new drugs and potential market opportunities.

**Questions about the Compound or Salt:**
1. What specific medical conditions could this compound or salt potentially treat?
2. How does the chemical structure of formula (I) differ from existing compounds in the pharmaceutical industry?

**Frequently Updated Research:**
Researchers may continue to explore the potential therapeutic applications of the compound or salt, leading to further advancements in drug development.


==Original Abstract Submitted==

The present invention provides a compound, or a pharmaceutically acceptable salt thereof, of formula (I):



[[Category:A61K31/5377]]
[[Category:A61K31/519]]
[[Category:C07D487/14]]
[[Category:C07D519/00]]
[[Category:CPC_A61K31/5377]]